219 related articles for article (PubMed ID: 8269604)
21. Minocycline as a modulator of chemotherapy and hyperthermia in vitro and in vivo.
Teicher BA; Holden SA; Liu CJ; Ara G; Herman TS
Cancer Lett; 1994 Jul; 82(1):17-25. PubMed ID: 8033065
[TBL] [Abstract][Full Text] [Related]
22. Allosteric effectors of hemoglobin as modulators of chemotherapy and radiation therapy in vitro and in vivo.
Teicher BA; Wong JS; Takeuchi H; Gravelin LM; Ara G; Buxton D
Cancer Chemother Pharmacol; 1998; 42(1):24-30. PubMed ID: 9619754
[TBL] [Abstract][Full Text] [Related]
23. Cyclocreatine in cancer chemotherapy.
Teicher BA; Menon K; Northey D; Liu J; Kufe DW; Kaddurah-Daouk R
Cancer Chemother Pharmacol; 1995; 35(5):411-6. PubMed ID: 7850923
[TBL] [Abstract][Full Text] [Related]
24. The angiogenesis inhibitor beta-cyclodextrin tetradecasulfate inhibits ecto-protein kinase activity.
Skubitz KM; Ehresmann DD
Cell Mol Biol; 1992 Sep; 38(6):543-60. PubMed ID: 1284648
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo.
Teicher BA; Holden SA; Herman TS; Epelbaum R; Pardee AB; Dezube B
Anticancer Res; 1991; 11(4):1555-60. PubMed ID: 1746913
[TBL] [Abstract][Full Text] [Related]
26. The proteasome inhibitor PS-341 in cancer therapy.
Teicher BA; Ara G; Herbst R; Palombella VJ; Adams J
Clin Cancer Res; 1999 Sep; 5(9):2638-45. PubMed ID: 10499643
[TBL] [Abstract][Full Text] [Related]
27. Combined treatment with verapamil, a calcium channel blocker, and B428, a synthetic uPA inhibitor, impairs the metastatic ability of a murine mammary carcinoma.
Todaro LB; Ladeda V; Bal de Kier Joffé E; Farías EF
Oncol Rep; 2003; 10(3):725-32. PubMed ID: 12684650
[TBL] [Abstract][Full Text] [Related]
28. Acute in vivo resistance in high-dose therapy.
Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
[TBL] [Abstract][Full Text] [Related]
29. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo.
Donnelly ET; Kelley M; Rockwell S
Cancer Chemother Pharmacol; 2004 Jan; 53(1):43-50. PubMed ID: 14574460
[TBL] [Abstract][Full Text] [Related]
30. Antitumor activity of cryptophycins: effect of infusion time and combination studies.
Menon K; Alvarez E; Forler P; Phares V; Amsrud T; Shih C; Al-Awar R; Teicher BA
Cancer Chemother Pharmacol; 2000; 46(2):142-9. PubMed ID: 10972484
[TBL] [Abstract][Full Text] [Related]
31. PEG-hemoglobin: effects on tumor oxygenation and response to chemotherapy.
Teicher BA; Ara G; Herbst R; Takeuchi H; Keyes S; Northey D
In Vivo; 1997; 11(4):301-11. PubMed ID: 9292296
[TBL] [Abstract][Full Text] [Related]
32. Effect of fluosol-DA/carbogen on etoposide/alkylating agent antitumor activity.
Teicher BA; Bernal SD; Holden SA; Cathcart KN
Cancer Chemother Pharmacol; 1988; 21(4):281-5. PubMed ID: 3131032
[TBL] [Abstract][Full Text] [Related]
33. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263
[TBL] [Abstract][Full Text] [Related]
34. [Minocycline potentiates the antimetastatic effect of boanmycin].
Liu JG; Jiang M; Xu LN; Zhen YS
Yao Xue Xue Bao; 1995; 30(9):668-73. PubMed ID: 8701742
[TBL] [Abstract][Full Text] [Related]
35. Melphalan sensitivity as a function of progressive metastatic growth in two subpopulations of a mouse mammary tumour.
Miller BE; Miller FR; Machemer T; Heppner GH
Br J Cancer; 1993 Jul; 68(1):18-25. PubMed ID: 8318410
[TBL] [Abstract][Full Text] [Related]
36. Affinity of fibroblast growth factors for beta-cyclodextrin tetradecasulfate.
Yuen SN; Folkman J; Weisz PB; Joullie MM; Ewing WR
Anal Biochem; 1990 Feb; 185(1):108-11. PubMed ID: 2344037
[TBL] [Abstract][Full Text] [Related]
37. A carbonic anhydrase inhibitor as a potential modulator of cancer therapies.
Teicher BA; Liu SD; Liu JT; Holden SA; Herman TS
Anticancer Res; 1993; 13(5A):1549-56. PubMed ID: 8239534
[TBL] [Abstract][Full Text] [Related]
38. Synergistic anti-tumor activity of a novel immunomodulator, BCH-1393, in combination with cyclophosphamide.
Kadhim S; Penney C; Lagraoui M; Heibein J; Attardo G; Zacharie B; Connolly T; Gagnon L
Int J Immunopharmacol; 2000 Sep; 22(9):659-71. PubMed ID: 10884587
[TBL] [Abstract][Full Text] [Related]
39. Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma.
Anderson IC; Shipp MA; Docherty AJ; Teicher BA
Cancer Res; 1996 Feb; 56(4):715-8. PubMed ID: 8631001
[TBL] [Abstract][Full Text] [Related]
40. Effect of lonidamine on the cytotoxicity of four alkylating agents in vitro.
Rosbe KW; Brann TW; Holden SA; Teicher BA; Frei E
Cancer Chemother Pharmacol; 1989; 25(1):32-6. PubMed ID: 2590999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]